Jarie Bolander

Those are roughly going to be, when they convert, about 1,700 sensors, roughly, give or take.

And again, sometimes we start talking to them, and then they say, oh, we have this requirement, and then it kind of starts to steamroll.

Like, oh, well, we can use it for this, and we can use it for this.

Yeah, they get more ideas.

Yeah, and we're providing a platform to allow them to do that.

Yeah, that's correct.

Okay, great.

Yeah.

Well, there's a big disruption going on.

The Affordable Care Act is really pushing suppliers to do more of a value-based approach instead of a volume-based approach.

Will that help or hurt you?

Oh, it's going to help us tremendously.

That's been the forcing function and the disruption in what we're doing because quality is going to matter a lot more.

I know it sounds kind of crazy, but

A lab would get paid if they ran any old sample, even if it was bad.

That was the old model.

A new model is they're not going to do that anymore.

It's going to help everyone.

It's really a push for more quality, reducing medical errors, allowing a diagnosis, which

70% of a diagnosis depends on a lab test.